Publicaciones en las que colabora con ALBERTO MUÑOZ LLARENA (10)

2023

  1. Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?

    Hereditary Cancer in Clinical Practice, Vol. 21, Núm. 1

2015

  1. Efficacy and safety of fixed-dose-rate infusions of gemcitabine plus erlotinib for advanced pancreatic cancer

    Journal of Analytical Oncology, Vol. 4, Núm. 1, pp. 44-51

2014

  1. Bevacizumab in combination with FOLFIRI in the first-line treatment of patients with advanced colorectal cancer: A single-institution experience

    Journal of Analytical Oncology, Vol. 3, Núm. 1, pp. 26-32

  2. Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 10

2013

  1. Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells

    PLoS ONE, Vol. 8, Núm. 5

2012

  1. Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

    Molecular Cancer, Vol. 11

2010

  1. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

2007

  1. Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer [3]

    Acta Oncologica

  2. Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer [5]

    Annals of Oncology

2005

  1. Extravasation of docetaxel: A red hand syndrome

    Archives of Dermatology